Tolerance of Two Forms of Vitamin C in Acid-sensitive Adults
A Randomized, Double-blind, Crossover Study Comparing the Tolerance of Two Forms of Vitamin C in Acid Sensitive Adults
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this study is to compare the tolerance of two forms of vitamin C in adults with sensitivity to acidic foods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 14, 2013
CompletedFirst Posted
Study publicly available on registry
June 10, 2013
CompletedJune 10, 2013
June 1, 2013
3 months
May 14, 2013
June 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline Gastrointestinal Symptom Rating Scale at 5 and 10 days
0, 5 and 10 days
Study Arms (2)
Calcium ascorbate -> ascorbic acid
EXPERIMENTALAscorbic acid -> calcium ascorbate
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Healthy as determined by laboratory results and medical history
- Females not of child bearing potential
- Self-reported sensitivity to acidic foods
- Agrees to consume a low vitamin C diet
You may not qualify if:
- Pregnant, breastfeeding, or planning to become pregnant during the trial
- Use of medications known to interact with vitamin C or cause epigastric effects
- Use of supplements containing containing vitamin C
- Duodenal ulcer or gastric ulcer, gastritis, hiatus hernia, or gastroesophageal reflux disease (GERD) within past 3 months
- Use of antacids and/or acid suppressors within 4 weeks of randomization
- History of irritable bowel syndrome and related disorders
- Alcohol use \> 2 standard alcoholic drinks per day; alcohol or drug abuse within the past year
- History of cardiac disease within the past 6 months
- History of or current diagnosis of cancer
- Uncontrolled hypertension
- Unstable renal and/or liver disease
- History of kidney stones
- Unstable psychiatric disorder
- History of or current immunocompromise
- History of hemoglobinopathies
- +9 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NBTY, Inc.lead
- KGK Science Inc.collaborator
- Moyad, Mark MD MPHcollaborator
Study Sites (1)
KGK Synergize, Inc
London, Ontario, N6A 5R8, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Crowley, MD
KGK Science Inc.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2013
First Posted
June 10, 2013
Study Start
March 1, 2008
Primary Completion
June 1, 2008
Last Updated
June 10, 2013
Record last verified: 2013-06